Germline BRCA1/2 carriers were associated with a younger age at diagnosis, greater Ki67 index values, higher frequencies of bilateral breast cancer, positive lymph node status, and a family history of breast or ovarian cancer (FBOC). This evidence concerns the gene MKI67 and breast cancer.